latest news releases from the newsroom
Infinity Pharmaceuticals, Inc.
Infinity Announces the Promotion of Adelene Q. Perkins to President and Chief Business Officer
CAMBRIDGE, Mass., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced the promotion of Adelene Q. Perkins to president and chief business officer. In this position, Ms. Perkins will continue to have responsibility for all of Infinity's business functions, including corporate and product strategy, business development, finance, organizational development and human resources, investor and public relations, legal, and facilities and operations.
Kiwa Bio-Tech Products Group Corporation
Kiwa Holds Joint New Products Press Conference With Jiangsu Technology Union
BEIJING and CLAREMONT, Calif., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Kiwa Bio-Tech Products Group Corporation (OTCBB:KWBT) and Jiangsu Technology Union Eco-Fertilizer Co., Ltd ("Jiangsu Technology Union") held a joint new bio-fertilizer products press conference. New products developed jointly by both parties have successfully passed trail tests and will be launched to the market in the 4th quarter of 2008. New products being introduced at this time were developed with Kiwa's latest technology and produced by Jiangsu Technology Union. The new bio-fertilizer products contain the highest amount of live bacteria among all organic fertilizers in today's market; furthermore, they are the only products that meet standards of Microbial Organic Fertilizer promulgated by the Ministry of Agriculture of the People's Republic of China.
Aastrom Biosciences, Inc.
Aastrom Biosciences Receives Notification That NASDAQ Issued Temporary Suspension of Certain Continued Listing Requirements
ANN ARBOR, Mich., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, announced that the Company received notification from the Listings Qualifications Department of The Nasdaq Stock Market LLC ("NASDAQ") that, given the current extraordinary market conditions, NASDAQ had suspended enforcement of the rules requiring a minimum $1.00 per share closing bid price and a minimum market value of publicly held shares through Friday, January 16, 2009. As previously announced, Aastrom had been given until December 15, 2008 to evidence a closing bid price of $1.00 or more for a minimum of ten consecutive business days to regain compliance. As a result of NASDAQ's suspension, Aastrom now has until March 20, 2009 to regain compliance with the $1.00 minimum closing bid price rule in order to remain listed on the Nasdaq Capital Market.